Brain HealthResearch PaperPaywall

Chronic Inflammation Hits Male and Female APOE4 Mice Differently

Aged APOE4 mice showed a sex split under repeated inflammatory stress: higher male mortality and greater brain inflammatory changes in females.

Friday, October 16, 2026 1 view
Published in Behav Brain Res
An aged laboratory mouse beside a labeled cage while a researcher examines a stained mouse brain section under a microscope

Summary

An aging mouse study suggests that biological sex shapes how the Alzheimer's risk gene APOE4 interacts with chronic inflammation. Researchers gave male and female mice carrying two copies of APOE4 repeated injections of a bacterial substance that triggers inflammation. Male mice had significantly increased mortality, while females showed greater brain changes linked to inflammation and altered activity of genes involved in nerve insulation. The researchers also found signs that the mice became tolerant to repeated exposure. These findings support studying males and females separately when investigating inflammation and brain aging. They do not establish prevention or treatment recommendations for humans. This summary is based on the abstract only, which does not provide sample sizes or detailed cognitive results. Increased male mortality may also have affected comparisons of thinking and memory.

Detailed Summary

Chronic inflammation may help connect aging with declining brain health. The APOE4 gene variant increases Alzheimer's disease risk, but its effects on inflammatory responses may differ between males and females. Understanding those differences could help researchers design better studies of prevention and treatment, although animal findings cannot establish what works in humans.

Researchers studied male and female mice carrying two copies of APOE4 at 15 to 16 months of age. Mice received abdominal injections of either a bacterial inflammatory trigger called lipopolysaccharide, or a control treatment, three times weekly for 17 doses. Researchers tracked weight, tested behavior during later injections, and measured inflammatory and other biological signals in blood and brain tissue.

Male mice exposed to the inflammatory trigger had significantly increased mortality, suggesting greater vulnerability throughout the body. Female mice showed more pronounced brain changes related to inflammation and altered activity of genes involved in maintaining myelin, the insulating covering around nerve fibers. The authors also reported findings suggesting tolerance to repeated exposure, rather than a uniformly escalating inflammatory response.

These findings suggest that the same inflammatory challenge can produce different patterns of harm depending on sex in this aging mouse model. They support analyzing males and females separately in research on APOE4 and brain aging. They do not show that women or men carrying APOE4 need a particular drug, supplement, or lifestyle change, and they do not establish an effective strategy for preventing Alzheimer's disease.

This summary is based on the abstract only. Sample sizes, numerical effect estimates, and detailed cognitive results were not provided there. Higher mortality among males may have distorted comparisons of cognition among survivors. Because all mice carried APOE4, the study cannot establish whether these responses are unique to that variant. Repeated bacterial toxin injections also do not fully reproduce chronic inflammation in naturally aging humans.

Key Findings

  • Repeated inflammatory exposure significantly increased mortality in aged male APOE4 mice; the abstract does not report the magnitude.
  • Female mice showed greater brain changes related to inflammation and altered expression of genes involved in myelin maintenance.
  • The authors reported signs of tolerance to repeated inflammatory exposure, complicating interpretation of the chronic challenge.
  • Higher male mortality may have biased cognitive comparisons among surviving mice.
  • The findings support sex-specific research analyses, not changes to treatment or supplement use in human APOE4 carriers.

Methodology

Male and female homozygous APOE4 mice, aged 15–16 months, received intraperitoneal injections of 0 or 0.25 mg/kg lipopolysaccharide three times weekly for 17 doses. Behavioral testing occurred from injections 12 through 17; researchers monitored weight and assessed systemic and brain inflammatory markers, antioxidant-related genes, myelin-related genes, and neurotrophin-related transcripts. Sample sizes, randomization, and blinding are not described in the abstract.

Study Limitations

This summary is based on the abstract only, which omits sample sizes, numerical effect estimates, and detailed cognitive outcomes. Increased male mortality may have introduced survivor bias, while apparent tolerance complicates interpretation of repeated exposure. The mouse injection model does not fully reproduce human aging, and the absence of another APOE genotype prevents conclusions about APOE4-specific effects.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: